ReviewNeuropsychology review2023
Current Potential for Clinical Optimization of Social Cognition Assessment for Frontotemporal Dementia and Primary Psychiatric Disorders.
Review in Neuropsychology review, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.
- Facial expression recognition deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic investigation of effects of phenotypic variant, task modality, geographical region and symptomatic specificity.Journal of neurology · 2023Pooled it
- Call to action on social cognition measures in clinical research.Schizophrenia research. Cognition · 2026Article
- Commentary on Ziermans, Hadjúk, Pinkham et al. "Call to action on social cognition measures in clinical research" and on Happé's commentary to the call to action.Schizophrenia research. Cognition · 2026Article
- International consensus for the assessment of social cognition in neurocognitive disorders: framework definition and clinical recommendations of the SIGNATURE initiative.Alzheimer's research & therapy · 2025Article
- Understanding barriers and optimizing socio-cognitive assessment in the diagnosis of neurocognitive disorders.Journal of neuropsychology · 2025Article
- Fourteen years later: Reviewing the diagnostic criteria for behavioral-variant frontotemporal dementia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Article
- Harmonizing cross-cultural and transdiagnostic assessment of social cognition by expert panel consensus.Schizophrenia (Heidelberg, Germany) · 2025Article
- The 36-Item Yoni Task: Normative Data for the Clinical Assessment of Theory of Mind.Journal of clinical medicine · 2024Article
- Answer to "Current Potential for Clinical Optimization of Social Cognition Assessment for Frontotemporal Dementia and Primary Psychiatric Disorders".Neuropsychology review · 2023Article
- Frontotemporal lobar degeneration.Nature reviews. Disease primers · 2023Review
Corrections and comments
- Commented on by
Authors and funding
9 authors at 7 institutions in 7 countries.
Funding
Abstract
Dodich and colleagues recently reviewed the evidence supporting clinical use of social cognition assessment in behavioral variant frontotemporal dementia (Dodich et al., 2021). Here, we comment on their methods and present an initiative to address some of the limitations that emerged from their study. In particular, we established the social cognition workgroup within the Neuropsychiatric International Consortium Frontotemporal dementia (scNIC-FTD), aiming to validate social cognition assessment for diagnostic purposes and tracking of change across clinical situations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.